ParrasAlbert Profile Banner
Parras Alberto Profile
Parras Alberto

@ParrasAlbert

Followers
202
Following
249
Media
1
Statuses
122

Ph.D Biotechnology | Entrepreneur | VivoArchitect Founder | Longevity | Aging | Preclinical Mouse | Triathlete

Lausanne, Switzerland
Joined December 2016
Don't wanna be here? Send us removal request.
@KristerKauppi
Krister Kauppi - Rapamycin Longevity Lab
4 days
It all started one night when I woke up with the realization that we needed to establish a partnership with the Reprogramming Lab (@ReprogLab), a cutting‑edge stealth biotech startup. The potential of combining interventions that both reverse and slow aging is too important to
5
6
39
@pumpdotscience
Pump Science
7 days
it's a great week to pump science let's race some flies you ready?
29
13
90
@eterna_labs
Eterna Labs
7 days
🧾 [Log #ΞL-050] — From Worms to Flies to Mice Observation: Rapamycin now enters the mammalian phase of experimentation. Thanks to VivoArchitect, founded by @ParrasAlbert a preclinical contract research organization, Eterna Labs and the Rapamycin Longevity Lab are expanding
@pumpdotscience
Pump Science
10 days
live with the micestro https://t.co/DAchCA3byn
6
4
26
@pumpdotscience
Pump Science
11 days
we are going to stream mice experiments all over the internet thanks to the micestro @ParrasAlbert bring your questions its open mice night https://t.co/DAchCA3byn
15
13
63
@BlupillAging
$BLUPILL
16 days
Why $BLUPILL? Too many safe, approved compounds never get retested for what matters: longevity. Sildenafil (the OG blue pill): – Boosts blood flow and oxygen delivery – Linked to lower Alzheimer’s risk and longer lifespan – Shows signs of neuroprotection and metabolic
14
4
27
@TrenchTalkDaily
Trench Talk
24 days
How to build successful products in crypto Volume 004: The Mission of @pumpdotscience w/ @benjileibo & @Koios9
9
6
94
@pumpdotscience
Pump Science
1 month
the arena is now packed with challengers which will be king anon?
18
9
78
@KristerKauppi
Krister Kauppi - Rapamycin Longevity Lab
1 month
Countdown begins! The first of three launches on @pumpdotscience is lifting off today at 10am PT / 7pm CET. Our mission at Rapamycin Longevity Lab (@omipalRLL) is to explore how far we can push the boundaries of human longevity through mTOR inhibitor based combinational
19
10
58
@pumpdotscience
Pump Science
1 month
18
30
145
@psy_dao
PsyDAO
2 months
buying desci in 2025 is like buying bitcoin in 2015
9
10
61
@Aubrai_
Aubrai
2 months
Running large-scale longevity experiments is not cheap. A single study with 1,000 mice costs hundreds of thousands upfront. Each mouse is a few hundred dollars before interventions even begin. Add cell and gene therapies, labor, and front-loaded damage repair, and the bill
74
50
273
@ParrasAlbert
Parras Alberto
2 years
Excited to announce @vivoarchitect is live! We link global firms with Europe's best mouse preclinical facilities. Swiss precision & ethics at lower costs. Check us out: https://t.co/PyVoQaijeZ. Let's innovate with integrity! #PreclinicalResearch #Mice #LifeSciences
0
1
5
@ParrasAlbert
Parras Alberto
2 years
Congrats @Albavalvil and @sarapico7, fantastic work! It was smart to induce reprogramming exclusively in post-mitotic cells @OcampoLab. Thrilled to have contributed to it! https://t.co/3Cmd86DyIW
Tweet card summary image
biorxiv.org
In vivo reprogramming through the forced expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) has demonstrated great potential for reversing age-associated phenotypes, as the combination of these...
@sarapico7
Sara Picó, PhD
2 years
Happy to share our latest preprint! 🐭🧬We conducted a comparative analysis across multiple reprogrammable strains, tissues, and expression methods, presenting a comprehensive atlas for improving in vivo reprogramming research! @Albavalvil @OcampoLab https://t.co/5LbfB8lphn
0
0
6
@stem_feed
STEM
2 years
Which is correct?
65
37
336
@Paddy_Barrett
Dr Paddy Barrett
2 years
Being in the top 5% of V02 Max for the population means you are 5 times less likely to die over a 10-year time horizon compared to someone in the bottom 25%. There is almost nothing medicine that offers that kind of survival advantage.
28
99
817
@ParrasAlbert
Parras Alberto
2 years
This great work is the result when a talented bioinformatician (@kgiperez ), an in vivo scientist (myself) collaborate under the supervision of @aocampox. Many thanks to @sarapico7 for her huge contribution during the revision and @prof_horvath and colleges!
@OcampoLab
Ocampo Lab
2 years
Latest paper from the lab where we analyze epigenetic age in multiple mouse models of premature aging. Importantly, our data reinforces the link between DNA damage and epigenetic dysregulation. Congratulations to all the authors!! https://t.co/JmQGvMTIuq
0
1
8
@kgiperez
Kevin Perez
2 years
Our first blog post about our journey @epiterna_ building a high-throughput screening platform for lifespan extending drugs is out! https://t.co/7RHxTlBfrk
1
1
6